Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inflammation and tuberculosis: host‐directed therapies

10 Apr 2014

Abstract excerpt

Tuberculosis (TB) is an airborne infectious disease that kills almost two million individuals every year. Multidrug-resistant (MDR) TB is caused by strains of Mycobacterium tuberculosis (M. tb) resistant to isoniazid and rifampin, the backbone of first-line antitubercular treatment. MDR TB affects an estimated 500,000 new patients annually. Genetic analysis of drug-resistant MDR-TB showed that airborne...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Tuberculosis
Share to Pneumocystis jirovecii pneumonia detection and treatment
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24717092
DOI: 10.1111/joim.12256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inflammation and tuberculosis: host‐directed therapiesPMID 24717092Read ↗

Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?Semantic proximity Read ↗

Inflammation in tuberculosis: interactions, imbalances and interventionsSemantic proximity Read ↗

The Troika Host–Pathogen–Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical OutcomesSemantic proximity Read ↗

Beyond the Clinic: The Activation of Diverse Cellular and Humoral Factors Shapes the Immunological Status of Patients with Active TuberculosisSemantic proximity Read ↗

Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?Semantic proximity Read ↗

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in TuberculosisSemantic proximity Read ↗

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.Semantic proximity Read ↗

Can We Exploit Inflammasomes for Host-Directed Therapy in the Fight against Mycobacterium tuberculosis Infection?Semantic proximity Read ↗

Advances in understanding immune homeostasis in latent tuberculosis infectionSemantic proximity Read ↗

The immune response in tuberculosis.Semantic proximity Read ↗

Host-directed therapies offer novel opportunities for the fight against tuberculosisSemantic proximity Read ↗

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.